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Abstract The objective was to
evaluate the presence of a positive
family history (FH) of vascular risk
factors between patients with
migraine with aura (MA) and
migraine without aura (MO), and in
chronic migraine (CM) compared to
other headache types. As migraine
patients are typically too young to
have developed vascular events,
studying older relatives of migraine
patients may be a practical means
of evaluating associations between
vascular risk factors and migraine.
A cross-sectional study of a clinic-
based sample of adults with
migraine headache was carried out
at the University of Utah. Predictor
variables comprised first or second
degree relatives with stroke, hyper-
tension, diabetes or hypercholes-
terolaemia. Outcome measures
comprised diagnosis of MA, MO or
CM according to the revised
International Headache Society cri-
teria. There was no significant dif-
ference in FH of vascular risk fac-
tors in MA compared to MO
(adjusted OR 1.04, 95% CI
0.61–1.78). CM was associated
with a decreased risk of FH of
stroke (OR=0.11, 95% CI
0.02–0.87, p=0.036). There was no
significant difference in FH of vas-
cular risk factors in MA patients
compared to MO. CM patients were
more likely to have a negative FH
of stroke compared to other
headache types, suggesting that CM
is likely a neuronal disease rather
than a vascular one.
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Introduction
The relationship between migraine and stroke has been the
subject of repeated study [1]. There appears to be a clear
correlation between migraine and stroke or other cardiovas-
cular events in rare genetic conditions such as cerebral auto-
somal dominant arteriopathy with subcortical infarctions
and leukoencephalopathy (CADASIL), mitochondrial
encephalopathy with lactic acidosis and stroke-like episodes
(MELAS) and the familial dyslipoproteinaemias [2].
Association between the common forms of migraine, stroke
and other vascular risk factors has been shown in several
large population-based studies [3, 4]. An increase in vascu-
lar events in parents and grandparents of children with
migraine compared to control subjects has been document-
ed previously [5]. One goal of this study was to compare
family history of vascular risk factors between patients with
migraine with aura (MA) and migraine without aura (MO).
The potential relationship between vascular risk factors
and chronic headache deserves attention, given the long-
term consequences of both conditions for patients. A sub-
set of patients with episodic MO undergo malignant trans-
formation to a debilitating chronic form of the disorder,
also known as chronic or transformed migraine [6].
Previous investigations on the aetiology, modifying factors
and treatment of chronic headaches have been difficult to
evaluate, as this heterogeneous group of disorders was usu-
ally classified as “chronic daily headache” and not as sep-
arate clinical entities [7]. The newly revised International
Headache Society (IHS) criteria address this issue and pro-
vide specific diagnostic criteria for chronic migraine
(CM), which allow standardisation of patient classification
[8]. We assessed the prevalence of positive family history
(FH) of vascular risk factors in patients with CM.
Methods
Study design
We conducted a cross-sectional study using the University of
Utah Headache Clinic Database. The database was originally
created to collect clinical/genetic data for patients in order to
identify headache predisposition genes and the family history
data are extremely detailed and complete. Data collected include
age of onset of headache pain, headache diagnoses, frequency,
duration, change in headache symptoms, medications, investiga-
tions, co-morbidities and detailed family history.
Subjects
Study subjects were adult patients who attended the University
of Utah Headache Clinic and who gave informed consent to par-
ticipate in the study between 1999 and 2003. Subjects for whom
complete data are not available or with a primary diagnosis other
than migraine were excluded from the study. All subjects were
initially classified according to the 1988 IHS criteria. Medical
records of subjects with a diagnosis of chronic daily headache,
transformed migraine or CM were reviewed and re-classified
according to the newly revised IHS criteria [8]. Only subjects
who met the IHS diagnostic criteria for CM were evaluated.
Predictor variables comprised first or second degree relative
with: (1) stroke, (2) hypertension, (3) diabetes and (4) hyper-
cholesterolaemia. Discrepancies in data were manually verified
as all clinical records were available.
Statistical analysis
Fisher’s exact test was the primary univariate statistical analysis
used, as most of the variables were categorical. Comparison of
means of continuous variables was carried out using Student’s t-
test. Multivariate logistic regression was used to adjust for
potential confounding factors and provide estimates of odds
ratios for MA/MO/CM status. The STATA 8.0 statistical soft-
ware package (Stata Corporation, College Station, TX) was used
for all analyses.
Results
A total of 303 subjects with a primary diagnosis of
migraine were enrolled in the study. Six subjects were
excluded (two had familial hemiplegic migraine, two had
post-traumatic headache as the primary diagnosis and
two subjects had incomplete medical records) yielding
297 eligible subjects. Of these, 126 had a diagnosis of
MA and 171 had MO. Subjects who carried a diagnosis of
both MA and MO were classified as having MA as the
primary diagnosis. Baseline demographic characteristics
appeared similar between the two groups. Univariate
analyses revealed no statistically significant difference in
MA vs. MO status compared by overall family history of
vascular risk factors. The differences in family history of
individual vascular risk factors (diabetes, hypertension,
hypercholesterolaemia, stroke) between the two groups
also appeared to be small and were not statistically sig-
nificant (Table 1).
The unadjusted odds ratio (OR) of MA compared to MO
was 1.05 (95% CI 0.64–1.7) for patients with a FH of vas-
cular risk factors. The OR adjusted for potential confound-
ing factors (age, race, headache frequency, gender) was
1.04 (95% CI 0.61–1.8). The ORs for individual cardiovas-
cular risk factors also appeared too small to be of clinical
significance (diabetes 0.91, 95% CI 0.55–1.5, hypertension
1.06, 95% CI 0.66–1.7, hypercholesterolaemia 1.21, 95%
CI 0.70–2.1, stroke 1.15, 95% CI 0.67–1.9).
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Table 1 Characteristics of patients with MO compared to MA
MO (n=171) MA (n=126) p-value*
Patients, n % Patients, n %
Gender 0.34
Male 30 17.5 17 13.5
Female 141 82.5 109 86.5
Race/ethnicity 0.36
Caucasian 169 98.8 121 96
Hispanic 1 0.6 3 2.4
Native American 1 0.6 1 0.8
Other 0 0.0 1 0.8
Mean age, years 40 42 0.22
Headaches/month, n 0.49
0–1 26 16.8 24 20.3
2–4 45 29.0 41 34.8
5–7 26 16.8 18 15.3
>8 58 37.4 35 29.7
FH vascular risk factors 119 69.6 89 70.6 0.85
FH diabetes 65 38.0 47 37.3 0.91
FH hypertension 73 42.7 57 45.2 0.66
FH hypercholesterolaemia 44 25.7 38 30.2 0.39
FH stroke 48 28.1 40 29.6 0.49
FH, positive family history
*Fisher’s exact test
Table 2 Characteristics of patients with CM compared to other migraine1
Other migraine (n=277) CM (n=20) p-value*
Patients, n % Patients, n %
Gender 0.46
Male 45 16.3 2 10.0
Female 232 83.8 18 90.0
Race/ethnicity <0.001
Caucasian 272 98.2 18 90.0
Hispanic 4 1.44 0 0.00
Native American 0 0.00 2 10.0
Other 1 0.36 0 0.00
Mean age, years 41.1 42.1 0.75
Headaches/month, n <0.001
0–1 49 19.2 0 0.00
2–4 84 32.9 0 0.00
5–7 40 15.7 0 0.00
>8 82 32.2 20 1001
FH vascular risk factors 191 69.0 17 85.0 0.13
FH diabetes 102 36.8 10 50.0 0.24
FH hypertension 118 42.6 12 60.0 0.13
FH hypercholesterolaemia 75 27.1 7 35.0 0.44
FH stroke 87 31.4 1 5.00 0.010
FH, positive family history
*Fisher’s exact test
1All patients with CM had at least 15 days of headache per month
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Of the 297 subjects, 112 had a diagnosis of chronic daily
headache, transformed migraine or CM. These patients were
reclassified according to the revised IHS guidelines follow-
ing review of medical records. Re-classification occurred as
follows: CM (20 patients), headache due to overuse of anal-
gesics (8 patients), ergotamines (2 patients) or
rebound/combination medication overuse (82 patients).
Baseline characteristics appeared similar in patients with
CM compared to other types of headache, with the excep-
tion of race/ethnicity and headache frequency (Table 2).
Univariate analyses revealed a significant decrease in
CM among patients with a FH of stroke (5%) compared to
a negative family history (31.4%), p=0.010. The unadjust-
ed OR of CM was 2.6 (95% CI 0.73–8.9) for patients with
a FH of vascular risk factors. The OR adjusted for poten-
tial confounding factors was 2.4 (95% CI 0.67–8.8). The
measures of association for individual cardiovascular risk
factors were as follows: family history of diabetes OR=1.7
(95% CI 0.69–4.3), family history of hypertension
OR=2.0 (95% CI 0.80–5.1) and family history of hyperc-
holesterolaemia OR=1.4 (95% CI 0.55–3.8). CM was
associated with a decreased family history of stroke
(OR=0.11, 95% CI 0.02–0.87, p=0.036). The ORs and
confidence intervals adjusted for potential confounding
factors were essentially unchanged (data not shown).
Discussion
The relationship between the common forms of migraine
and stroke remains an area of investigation. Data from
several studies suggest that migraine may be a risk factor
for the development of stroke [3, 4, 9–12] and MA may be
an important risk factor for stroke in women [12, 13]. The
mechanisms that underlie these observations are unclear
but a reasonable hypothesis could include the presence of
shared risk factors as a possible cause. As both migraine
and vascular disease have a demonstrated component of
heritability, it is possible that risk factors that predispose
to both conditions may be inherited traits. Migraine
patients are typically too young to have developed vascu-
lar events, and so we studied older relatives of migraine
patients as a means of evaluating the association between
vascular risk factors and migraine.
A recent population-based study found greater preva-
lence of white matter lesions in patients with MA and MO
compared to controls, suggesting a vascular basis for the
association between migraine and stroke [14]. Several
lines of evidence suggest MA is more strongly associated
with stroke than MO [3, 4, 12]. For our study, analysis of
associations between family history of vascular risk fac-
tors and MA compared to MO found only modest positive
associations, with confidence intervals that included no
associations at all. This is compatible with previously
reported findings [5], and very large population-based
studies may be required to fully elucidate this issue.
Chronic headache has been found to be an independent
predictor of stroke among men in one study [15]. We
found a large, statistically significant negative association
between family history of stroke and development of CM,
compared to non-CM migraine (OR=0.11, 95% CI
0.02–0.87, p=0.036). This suggests that stroke suscepti-
bility factors may not promote development of CM, com-
pared to other migraine types. Family history of diabetes,
hypertension and hypercholesterolaemia tended toward
positive association with CM, but were smaller and not
statistically significant. In addition, these conditions may
not be as accurately reported by patients as stroke. It is
possible that the pathophysiology of CM involves factors
completely unrelated to those traditionally associated with
vascular pathology, such as disruption of calcium home-
ostasis causing neuronal hyperexcitability [16], and that
CM may be considered a neuronal disease rather than a
vascular one. This finding merits further investigation
using a larger, prospective cohort or case-control study.
The strengths of the study include a well defined, homo-
geneous population, for which complete medical records
were available, and outcome ascertainment by a single
physician (KBD) with expertise in headache diagnosis and
treatment. Population stratification and confounding factors
such as alcoholism and smoking are greatly reduced given
the unique characteristics of this patient population. 
The main limitations of this study are its retrospective
nature and small sample size. There is also the potential
for selection/ascertainment bias as these patients are most
likely to have disabling illness and to present to a special-
ty clinic for care. However this is unlikely to influence
family history of vascular risk factors between the com-
parison groups. As our interest is in evaluation of stroke
risk factors and patients with severe, disabling migraine, a
clinic-based study is appropriate.
The observed differences in family history of vascular
risk factors among patients with different types of migraine
may potentially yield clues to understanding migraine biol-
ogy and pathogenesis. In addition, these findings may have
implications for treatment of patients with different
migraine types. In the case of CM, our study suggests that
traditional vascular risk factors may not be important in its
development, in contrast to previous studies [15]. This high-
lights the importance of further research in determining risk
factors for the development of this debilitating condition.
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